Skip to main content
. Author manuscript; available in PMC: 2009 Aug 10.
Published in final edited form as: J Public Health (Oxf). 2007 Jun 21;29(3):251–257. doi: 10.1093/pubmed/fdm040

Table 2.

Determinants of medication use in cerebrovascular disease (stroke and TIA) patients in 2005

N (%) Anti-platelet drugs Blood pressure lowering drugs* Statins
n (%) Prevalence ratio (95% CI) n (%) Prevalence ratio (95% CI) n (%) Prevalence ratio (95% CI)
Age
 Younger 168 (48) 137 (82) 1.00 116 (69) 1.00 108 (64) 1.00
 Older 181 (52) 135 (75) 0.91 (0.82, 1.02) 116 (64) 0.93 (0.79, 1.08) 75 (41) 0.64 (0.52, 0.79)

Social class
 Non-manual 177 (51) 143 (81) 1.00 122 (69) 1.00 95 (54) 1.00
 Manual 167 (49) 127 (76) 0.94 (0.84, 1.05) 107 (64) 0.93 (0.79, 1.08) 86 (52) 0.96 (0.78, 1.17)

Region
 North 112 (32) 91 (81) 1.00 69 (62) 1.00 61 (54) 1.00
 South 237 (68) 181 (76) 0.94 (0.84, 1.05) 163 (69) 1.12 (0.94, 1.32) 122 (51) 0.95 (0.77, 1.17)

Time since diagnosis
 <5 years 151 (43) 121 (80) 1.00 100 (66) 1.00 83 (55) 1.00
 5-10 years 109 (31) 88 (81) 1.00 (0.89, 1.14) 72 (66) 0.99 (0.84, 1.19) 56 (51) 0.93 (0.74, 1.18)
 >10 years 89 (26) 63 (71) 0.88 (0.76, 1.03) 60 (67) 1.02 (0.85, 1.22) 44 (49) 0.89 (0.69, 1.16)

Disability
 No 198 (57) 157 (79) 1.00 126 (64) 1.00 106 (54) 1.00
 Yes 151 (43) 115 (76) 0.96 (0.86, 1.08) 106 (70) 1.10 (0.95, 1.28) 77 (51) 0.95 (0.78, 1.17)

Type of vascular disease
 Stroke 159 (46) 118 (74) 1.00 116 (73) 1.00 87 (55) 1.00
 TIA 190 (54) 154 (81) 1.09 (0.97, 1.22) 116 (61) 0.84 (0.72, 0.97) 96 (51) 0.92 (0.76, 1.13)

Coronary heart disease
 No 234 (67) 177 (76) 1.00 143 (61) 1.00 104 (44) 1.00
 Yes 115 (33) 95 (83) 1.09 (0.98, 1.22) 89 (77) 1.27 (1.09, 1.46) 79 (61) 1.55 (1.28, 1.87)
*

Blood pressure lowering drugs include - thiazides, diuretics with potassium, beta-blockers, drugs affecting the rennin-angiotensin system and other antihypertensives, and calcium channel blockers